Form 483

Rommelag CDMO GmbH Form 483, 2020-02-18

FDA issued a Form 483 to Rommelag CDMO GmbH on 2020-02-18 with 3 public-safe observations.

483· Form 483 issuedAnimal Drugs & Feeds3 observations

Rommelag CDMO GmbH · Sulzbach-Laufen, Germany · Issued February 18, 2020

Overview

  • 3 public-safe observations are available for this inspection.
  • 3 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

18 Feb 2020
21 CFR 211.113(b)

Validation lacking for sterile drug products

Cited by Mindy M Chou

18 Feb 2020
21 CFR 211.160(b)

Scientifically sound laboratory controls

Cited by Mindy M Chou

18 Feb 2020
21 CFR 211.68(a)

Calibration/Inspection/Checking not done

Cited by Mindy M Chou

Inspected site

RCRommelag CDMO GmbHSulzbach-Laufen, Germany

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.113(b)Cited across public-safe Form 483 observations1x
21 CFR 211.160(b)Cited across public-safe Form 483 observations1x
21 CFR 211.68(a)Cited across public-safe Form 483 observations1x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 3 observations

The source PDF, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere